TSS
CVAC

Two Sigma Securities’s CureVac CVAC Stock Holding History

Two Sigma Securities’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,570
Closed -$57.4K – 1507
2025
Q2 		$57.4K Sell
10,570
-7,183
-40% -$28.5K 0.01% 1099
2025
Q1 		$49.2K Buy
+17,753
New +$61.8K 0.01% 1008
2023
Q1 		– Sell
-14,106
Closed -$85.1K – 2772
2022
Q4 		$85.1K Buy
+14,106
New +$104K ﹤0.01% 2091

Other funds holding CVAC

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BA
Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Securities's CVAC Position: Q3 2025 in Review

Two Sigma Securities sold out of CureVac (CVAC) in Q3 2025, closing a stake of 10,570 shares — an estimated $57.4K sold.

Two Sigma Securities first reported a position in CVAC in Q4 2022 and held it in 3 quarters. The position peaked at $85.1K in Q4 2022. 94 funds tracked by Wall St. Rank hold CVAC as of Q3 2025.

  • Two Sigma Securities reported no remaining CureVac position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 10,570 CureVac shares in Q3 2025, an estimated $57.4K.
  • Two Sigma Securities first reported a position in CureVac in Q4 2022 and held it in 3 quarters.
  • Two Sigma Securities's CureVac position peaked at $85.1K in Q4 2022.
  • 94 funds tracked by Wall St. Rank held CureVac as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.